These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 3258886
1. Induction of natural killer effectors from human thymus with recombinant IL-2. Michon JM, Caligiuri MA, Hazanow SM, Levine H, Schlossman SF, Ritz J. J Immunol; 1988 May 15; 140(10):3660-7. PubMed ID: 3258886 [Abstract] [Full Text] [Related]
2. Recombinant interleukin-2-activated intracavitary lymphocytes: phenotypic characteristics and effector function. Umiel T, Monselise J, Klein T, Rakovsky E, Fenig E, Lurie H, Adler A. J Biol Response Mod; 1989 Aug 15; 8(4):409-21. PubMed ID: 2787838 [Abstract] [Full Text] [Related]
3. Generation of lymphokine-activated killer cell activity from human thymocytes. Ramsdell FJ, Golub SH. J Immunol; 1987 Sep 01; 139(5):1446-53. PubMed ID: 2442246 [Abstract] [Full Text] [Related]
4. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity. Watanabe H, Narumi K, Stewart CC, Arbuck SG, Foon KA, Goldrosen MH. Anticancer Res; 1992 Sep 01; 12(6B):1925-33. PubMed ID: 1295440 [Abstract] [Full Text] [Related]
5. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype. Patel SS, Thiele DL, Lipsky PE. J Immunol; 1987 Dec 01; 139(11):3886-95. PubMed ID: 3500232 [Abstract] [Full Text] [Related]
6. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors. Mulé JJ, Krosnick JA, Rosenberg SA. J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444 [Abstract] [Full Text] [Related]
7. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures. Atzpodien J, Wisniewski D, Gulati S, Welte K, Knowles R, Clarkson B. Nat Immun Cell Growth Regul; 1987 Jan 15; 6(3):129-40. PubMed ID: 3114621 [Abstract] [Full Text] [Related]
8. Expression of the zeta protein subunit in CD3- NK effectors derived from human thymus. Beecher MS, Baiocchi RA, Linett ML, Krajewski CA, Caligiuri MA. Cell Immunol; 1994 May 15; 155(2):508-16. PubMed ID: 7514106 [Abstract] [Full Text] [Related]
9. The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes. Schwarz RE, Hiserodt JC. J Immunol; 1988 Nov 15; 141(10):3318-23. PubMed ID: 3263421 [Abstract] [Full Text] [Related]
10. Development of natural killer cells in human thymocyte culture: regulation by accessory cells. Blue ML, Levine H, Daley JF, Craig KA, Schlossman SF. Eur J Immunol; 1987 May 15; 17(5):669-73. PubMed ID: 3495443 [Abstract] [Full Text] [Related]
11. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets. Lebow LT, Jewett A, Bonavida B. J Immunol; 1993 Jan 01; 150(1):320-9. PubMed ID: 8417130 [Abstract] [Full Text] [Related]
12. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors. Heo DS, Whiteside TL, Kanbour A, Herberman RB. J Immunol; 1988 Jun 01; 140(11):4042-9. PubMed ID: 3286766 [Abstract] [Full Text] [Related]
13. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Perussia B, Ramoni C, Anegon I, Cuturi MC, Faust J, Trinchieri G. Nat Immun Cell Growth Regul; 1987 Jun 01; 6(4):171-88. PubMed ID: 2960890 [Abstract] [Full Text] [Related]
14. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex. Lanier LL, Le AM, Cwirla S, Federspiel N, Phillips JH. Fed Proc; 1986 Nov 01; 45(12):2823-8. PubMed ID: 3095151 [Abstract] [Full Text] [Related]
15. Human spleen and peripheral blood lymphocytes activated by interleukin-2 have similar phenotypic and functional characteristics. Voltarelli JC, Rayner AA, Garovoy MR, Stites DP. J Biol Response Mod; 1990 Feb 01; 9(1):103-7. PubMed ID: 2319257 [Abstract] [Full Text] [Related]
16. Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency. Garni-Wagner BA, Witte PL, Tutt MM, Kuziel WA, Tucker PW, Bennett M, Kumar V. J Immunol; 1990 Feb 01; 144(3):796-803. PubMed ID: 2136898 [Abstract] [Full Text] [Related]
17. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC. Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412 [Abstract] [Full Text] [Related]
18. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity. Anderson PM, Blazar BR, Bach FH, Ochoa AC. J Immunol; 1989 Feb 15; 142(4):1383-94. PubMed ID: 2521662 [Abstract] [Full Text] [Related]
19. Functional characterization of human thymocytes: a limiting dilution analysis of precursors with proliferative and cytolytic activities. Lopez-Botet M, Moretta L. J Immunol; 1985 Apr 15; 134(4):2299-304. PubMed ID: 3919089 [Abstract] [Full Text] [Related]
20. Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. Poggi A, Costa P, Morelli L, Cantoni C, Pella N, Spada F, Biassoni R, Nanni L, Revello V, Tomasello E, Mingari MC, Moretta A, Moretta L. Eur J Immunol; 1996 Jun 15; 26(6):1266-72. PubMed ID: 8647203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]